CanSino Biologics Inc.

HKEX:6185.HK

30.95 (HKD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q22017 Q12016 Q42016 Q22016 Q12015 Q4
Revenue 171.138114.282169.55154.546-79.467100.553323.64677.605130.435499.3551,213.9271,024.321,594.697466.75819.2161.64404.030.3540.0241.3340.5714.3284.3280.2830.2830.283000000
Cost of Revenue 52.03646.2331,048.482-624.854732.38665.187975.962-71.931165.143148.474251.165421.302401.258224.04414.2280.1600.3430.0160.0030.0880.0437.937028.41228.41228.41217.02517.02517.02512.91712.91712.917
Gross Profit 119.10168.05-878.932779.4-811.85435.367-652.317149.537-34.708350.881962.762603.0181,193.439242.7144.9891.48403.6870.3370.021.2470.532-33.6094.328-28.129-28.129-28.129-17.025-17.025-17.025-12.917-12.917-12.917
Gross Profit Ratio 0.6960.595-5.1845.04310.2160.352-2.0161.927-0.2660.7030.7930.5890.7480.520.260.90200.9150.9540.8580.9340.93-7.7651-99.394-99.394-99.394000000
Reseach & Development Expenses 89.15696.746176.313123.302188.607149.765229.191225.101166.81157.155222.948104.49281.492269.788251.76968.79468.3939.53357.15437.07729.35228.16232.3132.3124.51324.5130000000
General & Administrative Expenses 87.77537.069106.35948.0475.12160.54766.45971.97872.65564.10179.69950.64175.58914.87528.1221.8576.7635.077-15.81613.0114.17816.73116.87516.8756.2416.2415.1510.7970.7970.7970.4520.4520.452
Selling & Marketing Expenses 65.89246.586159.76164.7973.86154.983117.47860.23554.5934.3141.70429.53227.4127.178.4363.6542.8241.6482.5091.1041.4690.2051.3220-4.609-4.609-4.609-0.6-0.6-0.6-0.343-0.343-0.343
SG&A 153.66746.586266.12112.83213.91454.983183.937132.213128.726101.554119.69684.151103.07522.04536.55625.5119.5876.725-13.30714.1155.64716.93616.87516.8756.2416.2410.5430.1970.1970.1970.1090.1090.109
Other Expenses 0.526-0.00240.365-8.333-24.249-8.118-1.781-8.5570000000-14.1817.638-3.06824.947-1.172-0.0130.1-41.840000000000
Operating Expenses 180.571173.778353.476291.504324.051233.856347.257396.712153.763251.044342.762188.913354.817283.658263.78680.12385.61543.1968.79450.0241.76850.77650.14850.14829.64329.6430.5430.1970.1970.1970.1090.1090.109
Operating Income -75.585-174.881-957.151684.714-1,150.085-192.347-1,133.169-36.013-319.424112.98609.141394.756828.755-48.588-313.908-75.436-63.382-39.043-24.782-44.566-20.294-48.895-45.94-45.94-29.621-29.621-34.57-16.113-16.113-16.113-12.463-12.463-12.463
Operating Income Ratio -0.442-1.53-5.6454.4314.472-1.913-3.501-0.464-2.4490.2260.5020.3850.52-0.104-16.336-45.8810-9.689-70.075-1,870.175-15.208-85.557-10.614-10.614-104.668-104.668-122.156000000
Total Other Income Expenses Net 21.272-61.908433.736-857.463-271.6389.204596.022-569.286156.9737.91537.25658.823.83132.83693.1611.746-15.71815.94-38.52620.786-4.1523.6482.542.543.8813.8810000000
Income Before Tax -54.313-174.883-522.8-172.749-1,082.869-200.466-537.148-605.298-162.45120.895646.397453.556852.586-15.752-220.747-73.69-79.099-23.103-63.308-23.78-24.446-45.248-43.4-43.4-25.741-25.741-34.57-16.113-16.113-16.113-12.463-12.463-12.463
Income Before Tax Ratio -0.317-1.53-3.083-1.11813.627-1.994-1.66-7.8-1.2450.2420.5320.4430.535-0.034-11.488-44.8190-5.733-179.015-997.916-18.319-79.174-10.028-10.028-90.956-90.956-122.156000000
Income Tax Expense 0.964-4.787-10.287029.103-30.267-61.073-100.57364.1986.673.20756.793100.299-1.6380-1.74615.718-15.9438.526-20.7860000000000000
Net Income -55.277-170.096-497.702-143.601-701.881-139.548-435.02-486.649-109.175121.413580.494396.763951.247-14.114-220.747-71.943-94.817-7.163-101.834-2.994-24.446-45.248-43.4-43.4-25.741-25.741-34.57-16.113-16.113-16.113-12.463-12.463-12.463
Net Income Ratio -0.323-1.488-2.935-0.9298.832-1.388-1.344-6.271-0.8370.2430.4780.3870.597-0.03-11.488-43.7560-1.777-287.956-125.657-18.319-79.174-10.028-10.028-90.956-90.956-122.156000000
EPS -0.22-0.69-2.02-0.58-2.82-0.57-1.76-1.97-0.450.492.351.63.66-0.06-0.9-0.31-0.44-0.031-0.47-0.014-0.11-0.28-0.28-0.28-0.17-0.17-0.16-0.074-0.074-0.074-0.057-0.057-0.057
EPS Diluted -0.22-0.69-2.02-0.58-2.82-0.57-1.76-1.93-0.450.492.351.63.66-0.06-0.9-0.31-0.44-0.031-0.47-0.014-0.11-0.28-0.28-0.28-0.17-0.17-0.16-0.074-0.074-0.074-0.057-0.057-0.057
EBITDA 14.183-143.067-1,363.906684.714-1,092.39-185.999-1,133.169-36.013-281.038129.258625.419399.484840.728-43.86-309.18-75.436-58.941-35.125-21.112-40.958-17.476-45.965-42.595-42.595-26.986-26.986-31.566-13.99-13.99-13.99-10.862-10.862-10.862
EBITDA Ratio 0.083-1.252-8.0444.4313.746-1.85-3.501-0.464-2.1550.2590.5150.390.527-0.094-16.09-45.8810-8.717-59.698-1,718.768-13.097-80.429-9.842-9.842-95.357-95.357-111.539000000